Glassman Wealth Services Gilead Sciences, Inc. Transaction History

Glassman Wealth Services

$542 Million
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $9,232 - $10,469	126 Added 5.01%	2,640 $213,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $147 - $161	2 Added 0.08%	2,514 $188,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $3,952 - $4,508	-52 Reduced 2.03%	2,512 $193,000
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $1,468 - $1,673	19 Added 0.75%	2,564 $212,000
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $12,962 - $18,609	208 Added 8.9%	2,545 $218,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $13,753 - $15,710	231 Added 10.97%	2,337 $144,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $18,181 - $20,478	315 Added 17.59%	2,106 $130,000
Q1 2022 Aug 23, 2022	SELL	$57.92 - $72.58 $1,448 - $1,814	-25 Reduced 1.38%	1,791 $106,000
Q1 2022 Apr 14, 2022	BUY	$57.92 - $72.58 $9,093 - $11,395	157 Added 9.46%	1,816 $108,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $1,297 - $1,472	20 Added 1.22%	1,659 $120,000
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $31,408 - $33,885	464 Added 39.49%	1,639 $114,000
Q2 2021 Aug 04, 2021	BUY	$63.47 - $69.35 $253 - $277	4 Added 0.34%	1,175 $81,000
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $4,800 - $5,476	80 Added 7.33%	1,171 $76,000
Q4 2020 Feb 04, 2021	BUY	$56.65 - $64.55 $5,268 - $6,003	93 Added 9.32%	1,091 $64,000
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $21,051 - $26,469	-339 Reduced 25.36%	998 $63,000
Q2 2020 Aug 06, 2020	BUY	$72.34 - $84.0 $144 - $168	2 Added 0.15%	1,337 $103,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $13,590 - $17,407	217 Added 19.41%	1,335 $100,000
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $1,971 - $2,168	32 Added 2.95%	1,118 $73,000
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $312 - $345	5 Added 0.46%	1,086 $69,000
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $3,093 - $3,469	50 Added 4.85%	1,081 $73,000
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $16,070 - $18,002	257 Added 33.2%	1,031 $67,000
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $363 - $474	-6 Reduced 0.77%	774 $48,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $12,830 - $14,205	-180 Reduced 18.75%	780 $60,000
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $33,088 - $38,596	510 Added 113.33%	960 $68,000
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $2,347 - $2,756	33 Added 7.91%	450 $32,000
Q2 2017 Aug 09, 2017	BUY	N/A	417	417 $30,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account